Abstract
The growth hormone receptor (GHR) is expressed in brain regions that are known to participate in the regulation of energy homeostasis and glucose metabolism. We generated a novel transgenic mouse line (GHRcre) to characterize GHR-expressing neurons specifically in the arcuate nucleus of the hypothalamus (ARC). Here, we demonstrate that ARCGHR+ neurons are co-localized with agouti-related peptide (AgRP), growth hormone releasing hormone (GHRH), and somatostatin neurons, which are activated by GH stimulation. Using the designer receptors exclusively activated by designer drugs (DREADD) technique to control the ARCGHR+ neuronal activity, we demonstrate that the activation of ARCGHR+ neurons elevates a respiratory exchange ratio (RER) under both fed and fasted conditions. However, while the activation of ARCGHR+ promotes feeding, under fasting conditions, the activation of ARCGHR+ neurons promotes glucose over fat utilization in the body. This effect was accompanied by significant improvements in glucose tolerance, and was specific to GHR+ versus GHRH+ neurons. The activation of ARCGHR+ neurons increased glucose turnover and whole-body glycolysis, as revealed by hyperinsulinemic-euglycemic clamp studies. Remarkably, the increased insulin sensitivity upon the activation of ARCGHR+ neurons was tissue-specific, as the insulin-stimulated glucose uptake was specifically elevated in the skeletal muscle, in parallel with the increased expression of muscle glycolytic genes. Overall, our results identify the GHR-expressing neuronal population in the ARC as a major regulator of glycolysis and muscle insulin sensitivity in vivo.
Highlights
In the central nervous system (CNS), the growth hormone receptor (GHR) is present in regions known to participate in the regulation of feeding, energy balance, and glucose metabolism, including the hypothalamus, hippocampus, and amygdala [1,2,3]
We focused on studying the role of the in vivo activation of the GHR-expressing neurons in the arcuate nucleus of the hypothalamus (ARC) in the regulation of energy homeostasis and systemic glucose metabolism
We developed a novel GHR-driven cre mouse (GHRcre) that allowed us to both track and activate GHR-expressing neurons by directly enhancing the activity of the neurons in a non-invasive manner using designer receptors exclusively activated by designer drugs (DREADD) technology
Summary
In the central nervous system (CNS), the growth hormone receptor (GHR) is present in regions known to participate in the regulation of feeding, energy balance, and glucose metabolism, including the hypothalamus, hippocampus, and amygdala [1,2,3]. Mice lacking GHR, in the orexigenic agoutirelated peptide (AgRP) expressing neurons in the ARC, displayed impaired responses to fasting and food restriction, while the deletion of GHR from anorexigenic proopiomelanocortin (POMC) neurons in the ARC did not produce a significant metabolic phenotype [5,6] These results indicate unique roles of GHR signaling in the ARC neurons in metabolic control. We focused on studying the role of the in vivo activation of the GHR-expressing neurons in the ARC in the regulation of energy homeostasis and systemic glucose metabolism To this end, we developed a novel GHR-driven cre mouse (GHRcre) that allowed us to both track and activate GHR-expressing neurons by directly enhancing the activity of the neurons in a non-invasive manner using designer receptors exclusively activated by designer drugs (DREADD) technology.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.